Translating Early Outgrowth Cell Therapy into a Clinically Relevant Approach for Long Term Renoprotection
Current therapy for chronic kidney disease (CKD) is limited; however, recent studies have shown that a subpopulation of cells derived from the bone marrow, known as early outgrowth cells (EOCs), are able to attenuate kidney injury. Here we examined the efficacy of a modular tissue engineering system...
Main Author: | |
---|---|
Other Authors: | |
Language: | en_ca |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/42980 |